STUDY PROTOCOL
Accepted on 11 Jul 2025
Fruquintinib and sintilimab plus SOX as perioperative therapy for locally resectable advanced gastric/gastroesophageal junction (G/GEJ) adenocarcinoma : study protocol for a prospective, single-arm, phase II clinical trial
doi 10.3389/fimmu.2025.1638316
- 207 views